300 North Capital’s Celgene Corp CELG Stock Holding History

300 North Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-32,800	Closed	-$2.52M	–	126
2013 Q3	$2.52M	Sell	32,800 -4,200	-11%	-$294K	0.59%	68
2013 Q2	$2.16M	Buy	+37,000	New	+$2.23M	0.84%	51

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

300 North Capital's CELG Position: Q4 2013 in Review

300 North Capital sold out of Celgene Corp (CELG) in Q4 2013, closing a stake of 32,800 shares — an estimated $2.52M sold.

300 North Capital first reported a position in CELG in Q2 2013 and held it in 2 quarters. The position peaked at $2.52M in Q3 2013. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

300 North Capital reported no remaining Celgene Corp position as of Q4 2013 after selling out during the quarter.
300 North Capital sold 32,800 Celgene Corp shares in Q4 2013, an estimated $2.52M.
300 North Capital first reported a position in Celgene Corp in Q2 2013 and held it in 2 quarters.
300 North Capital's Celgene Corp position peaked at $2.52M in Q3 2013.
983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on 300 North Capital's 13F filing for Q4 2013, filed 14 Feb 2014.